Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Adrenergic (1)
- Adrenergic beta-Agonists (1)
- Age Factors (1)
- Aminophylline (1)
- Animals (1)
-
- Beta (1)
- Cardiac (1)
- Cardiotonic Agents (1)
- Cell Proliferation (1)
- Cells (1)
- Cells, Cultured (1)
- Cultured (1)
- Emission-Computed (1)
- Exercise Test (1)
- Group A (1)
- Humans (1)
- MAP Kinase Signaling System (1)
- Male (1)
- Member 2 (1)
- Myocardial Perfusion Imaging (1)
- Myocytes (1)
- Myocytes, Cardiac (1)
- Nuclear Receptor Subfamily 4 (1)
- Nuclear Receptor Subfamily 4, Group A, Member 2 (1)
- Rats (1)
- Rats, Sprague-Dawley (1)
- Receptors (1)
- Receptors, Adrenergic, beta (1)
- Single-Photon (1)
- Sprague-Dawley (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Nuclear Receptor Subfamily 4 Group A Member 2 Inhibits Activation Of Erk Signaling And Cell Growth In Response To Β-Adrenergic Stimulation In Adult Rat Cardiomyocytes, Sadia Ashraf, Yassmin K Hegazy, Romain Harmancey
Nuclear Receptor Subfamily 4 Group A Member 2 Inhibits Activation Of Erk Signaling And Cell Growth In Response To Β-Adrenergic Stimulation In Adult Rat Cardiomyocytes, Sadia Ashraf, Yassmin K Hegazy, Romain Harmancey
Journal Articles
Sustained elevation of sympathetic activity is an important contributor to pathological cardiac hypertrophy, ventricular arrhythmias, and left ventricular contractile dysfunction in chronic heart failure. The orphan nuclear receptor NR4A2 is an immediate early-response gene activated in the heart under β-adrenergic stimulation. The goal of this study was to identify the transcriptional remodeling events induced by increased NR4A2 expression in cardiomyocytes and their impact on the physiological response of those cells to sustained β-adrenergic stimulation. Treatment of adult rat ventricular myocytes with isoproterenol induced a rapid (<4 >h) increase in NR4A2 levels that was accompanied by a transient (<24 >h) increase …
Aminophylline Shortage And Current Recommendations For Reversal Of Vasodilator Stress: An Asnc Information Statement Endorsed By Scmr, Aiden Abidov, Vasken Dilsizian, Rami Doukky, W Lane Duvall, Christopher Dyke, Michael D Elliott, Fadi G Hage, Milena J Henzlova, Nils P Johnson, Ronald G Schwartz, Gregory S Thomas, Andrew J Einstein
Aminophylline Shortage And Current Recommendations For Reversal Of Vasodilator Stress: An Asnc Information Statement Endorsed By Scmr, Aiden Abidov, Vasken Dilsizian, Rami Doukky, W Lane Duvall, Christopher Dyke, Michael D Elliott, Fadi G Hage, Milena J Henzlova, Nils P Johnson, Ronald G Schwartz, Gregory S Thomas, Andrew J Einstein
Journal Articles
Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress is an important safety and comfort measure for patients experiencing such effects. While typically performed using intravenous aminophylline, recurrent shortages of this agent have led to a greater need to limit its use and consider alternative agents. This information statement provides background and recommendations addressing indications for vasodilator reversal, timing of a reversal agent, incidence of observed SISE with vasodilator stress, clinical and logistical considerations for aminophylline-based reversal, and alternative non-aminophylline based reversal protocols.